ABNX.PA Current Ratio

As of 2025-05-25, the Current Ratio of Abionyx Pharma SA (ABNX.PA) is 1.58.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

ABNX.PA Current Ratio - Historical Value

Date	Value
2024-12-31	1.58
2023-12-31	1.75
2022-12-31	1.49
2021-12-31	1.93
2020-12-31	2.79
2019-12-31	2.92
2018-12-31	1.5
2017-12-31	5.52
2016-12-31	4.29
2015-12-31	0.61

ABNX.PA Current Ratio - Peers Comparison

Ticker	Name	Value
ABVX.PA	Abivax SA	1.82
ACTI.ST	Active Biotech AB publ	4.4
AEGIR.ST	Aegirbio AB	1.64
ALCLS.PA	Cellectis SA	1.73
ALLR.ST	Allarity Therapeutics A/S	0.4
ALNEV.PA	Neovacs SA	1.03
ALNOV.PA	Novacyt SA	2.92
ALNOX.PA	Noxxon Pharma NV	1.84
ALPAT.PA	Plant Advanced Technologies PAT SA	2.11
ALPRE.PA	Predilife SA	3.22
ALZ.ST	Alzinova AB	2.16
COMBI.ST	Combigene AB	17.44
DBV.PA	Dbv Technologies SA	1.43
EVG.L	Evgen Pharma PLC	7.36
GEN.WA	Genomed SA	6.28
GKTX.PA	GenKyoTex SA	1.29
GUARD.ST	Guard Therapeutics International AB (publ)	3.14
GV.PA	Genomic Vision SA	0.91
IDOGEN.ST	Idogen AB	1.67
IMMU.ST	Mendus AB (publ)	4.29
IPH.PA	Innate Pharma SA	2.6
ISR.ST	ISR Immune System Regulation Holding AB (publ)	0.03
IVA.PA	Inventiva SA	0.92
LIDDS.ST	Lidds AB	4.86
MTPH.L	Midatech Pharma PLC	6.39
MVIR B.ST	Medivir AB	4.39
NANO.PA	Nanobiotix SA	1.04
PROMO.ST	Promore Pharma AB	3.33
RDG.WA	Read Gene SA	10.3
SCS.WA	Stem Cells Spin SA	0.16
SENZA.ST	SenzaGen AB	2.66
SIGHT.PA	Gensight Biologics SA	0.24
SPRINT.ST	Sprint Bioscience AB	1.14
TNG.PA	Transgene SA	1.79
TOL.ST	Toleranzia AB	2.5
VAL.L	ValiRx PLC	2.64
VLA.PA	Valneva SE	2.61
XINT.ST	Xintela AB	0.78